ask="76.070"
ask_size="2000"
average_daily_volume="573177"
bid="N/A"
bid_size="N/A"
book_value="11.382"
change="+1.655"
change_from_200_day_moving_average="1.724"
change_from_50_day_moving_average="-2.119"
change_from_52_week_high="-16.725"
change_From_52_week_low="23.525"
change_in_percent="+2.420%"
close="70.045"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.876"
ebitda="-230.87M"
eps_estimate_current_year="-6.140"
eps_estimate_next_quarter="-1.680"
eps_estimate_next_year="-6.720"
ex_dividend_date="N/A"
float_shares="37661000"
high="70.240"
high_52_weeks="86.770"
last_trade_date="1/24/2017"
last_trade_price="70.045"
last_trade_size="31769"
last_trade_time="4:00pm"
low="66.660"
low_52_weeks="46.520"
market_capitalization="2.86B"
moving_average_200_day="68.321"
moving_average_50_day="72.164"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.730"
open="68.630"
pe_ratio="N/A"
peg_ratio="-0.380"
percent_change_from_200_day_moving_average="+2.524%"
percent_change_from_50_day_moving_average="-2.937%"
percent_change_from_52_week_high="-19.275%"
percent_change_from_52_week_low="+50.570%"
previous_close="68.390"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.009"
price_per_sales="21830.836"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="10.260"
stock_exchange="NMS"
symbol="RARE"
volume="358223"
weeks_range_52="46.520 - 86.770"
